NOV. 14, 2024 – Only three medications are currently approved for the treatment of AUD, and expert opinion maintains these options are not suitable for all patients, and relapse is commonplace.
“I see so many patients who do not have good outcomes on the medications we have and who are desperate for help with their addiction,” said study leader Dr. Markku Lähteenvuo said. “We really do need more tools in the toolbox.”
But the study found that semaglutide (which is sold under brand names like Ozempic and Wegovy) and liraglutide (which is sold under the brand named Victoza) lowered the hospitalization risk by 22% and 21%, respectively.
Lähteenvuo and his team analyzed the medical records of 228,000 people diagnosed with alcohol use disorder from 2006 to 2023. All of these patients also had obesity or Type 2 diabetes.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…